Feature Engineering for Machine Learning using a Software-Based Approach for Machining Operations

2021 ◽  
pp. 525-534
Author(s):  
A. Dementyev ◽  
P. Kolar ◽  
M. Benesch ◽  
U. Teicher ◽  
R. Pätzold ◽  
...  
2021 ◽  
pp. 1-13
Author(s):  
C S Pavan Kumar ◽  
L D Dhinesh Babu

Sentiment analysis is widely used to retrieve the hidden sentiments in medical discussions over Online Social Networking platforms such as Twitter, Facebook, Instagram. People often tend to convey their feelings concerning their medical problems over social media platforms. Practitioners and health care workers have started to observe these discussions to assess the impact of health-related issues among the people. This helps in providing better care to improve the quality of life. Dementia is a serious disease in western countries like the United States of America and the United Kingdom, and the respective governments are providing facilities to the affected people. There is much chatter over social media platforms concerning the patients’ care, healthy measures to be followed to avoid disease, check early indications. These chatters have to be carefully monitored to help the officials take necessary precautions for the betterment of the affected. A novel Feature engineering architecture that involves feature-split for sentiment analysis of medical chatter over online social networks with the pipeline is proposed that can be used on any Machine Learning model. The proposed model used the fuzzy membership function in refining the outputs. The machine learning model has obtained sentiment score is subjected to fuzzification and defuzzification by using the trapezoid membership function and center of sums method, respectively. Three datasets are considered for comparison of the proposed and the regular model. The proposed approach delivered better results than the normal approach and is proved to be an effective approach for sentiment analysis of medical discussions over online social networks.


Sensors ◽  
2019 ◽  
Vol 19 (1) ◽  
pp. 210 ◽  
Author(s):  
Zied Tayeb ◽  
Juri Fedjaev ◽  
Nejla Ghaboosi ◽  
Christoph Richter ◽  
Lukas Everding ◽  
...  

Non-invasive, electroencephalography (EEG)-based brain-computer interfaces (BCIs) on motor imagery movements translate the subject’s motor intention into control signals through classifying the EEG patterns caused by different imagination tasks, e.g., hand movements. This type of BCI has been widely studied and used as an alternative mode of communication and environmental control for disabled patients, such as those suffering from a brainstem stroke or a spinal cord injury (SCI). Notwithstanding the success of traditional machine learning methods in classifying EEG signals, these methods still rely on hand-crafted features. The extraction of such features is a difficult task due to the high non-stationarity of EEG signals, which is a major cause by the stagnating progress in classification performance. Remarkable advances in deep learning methods allow end-to-end learning without any feature engineering, which could benefit BCI motor imagery applications. We developed three deep learning models: (1) A long short-term memory (LSTM); (2) a spectrogram-based convolutional neural network model (CNN); and (3) a recurrent convolutional neural network (RCNN), for decoding motor imagery movements directly from raw EEG signals without (any manual) feature engineering. Results were evaluated on our own publicly available, EEG data collected from 20 subjects and on an existing dataset known as 2b EEG dataset from “BCI Competition IV”. Overall, better classification performance was achieved with deep learning models compared to state-of-the art machine learning techniques, which could chart a route ahead for developing new robust techniques for EEG signal decoding. We underpin this point by demonstrating the successful real-time control of a robotic arm using our CNN based BCI.


2017 ◽  
Vol 280 ◽  
pp. 232-238 ◽  
Author(s):  
Zheng Li ◽  
Xianfeng Ma ◽  
Hongliang Xin

2021 ◽  
Vol 2021 ◽  
pp. 1-12
Author(s):  
Muhammad Waqar ◽  
Hassan Dawood ◽  
Hussain Dawood ◽  
Nadeem Majeed ◽  
Ameen Banjar ◽  
...  

Cardiac disease treatments are often being subjected to the acquisition and analysis of vast quantity of digital cardiac data. These data can be utilized for various beneficial purposes. These data’s utilization becomes more important when we are dealing with critical diseases like a heart attack where patient life is often at stake. Machine learning and deep learning are two famous techniques that are helping in making the raw data useful. Some of the biggest problems that arise from the usage of the aforementioned techniques are massive resource utilization, extensive data preprocessing, need for features engineering, and ensuring reliability in classification results. The proposed research work presents a cost-effective solution to predict heart attack with high accuracy and reliability. It uses a UCI dataset to predict the heart attack via various machine learning algorithms without the involvement of any feature engineering. Moreover, the given dataset has an unequal distribution of positive and negative classes which can reduce performance. The proposed work uses a synthetic minority oversampling technique (SMOTE) to handle given imbalance data. The proposed system discarded the need of feature engineering for the classification of the given dataset. This led to an efficient solution as feature engineering often proves to be a costly process. The results show that among all machine learning algorithms, SMOTE-based artificial neural network when tuned properly outperformed all other models and many existing systems. The high reliability of the proposed system ensures that it can be effectively used in the prediction of the heart attack.


2018 ◽  
Author(s):  
Khader Shameer ◽  
Kipp W. Johnson ◽  
Benjamin S. Glicksberg ◽  
Rachel Hodos ◽  
Ben Readhead ◽  
...  

ABSTRACTDrug repositioning, i.e. identifying new uses for existing drugs and research compounds, is a cost-effective drug discovery strategy that is continuing to grow in popularity. Prioritizing and identifying drugs capable of being repositioned may improve the productivity and success rate of the drug discovery cycle, especially if the drug has already proven to be safe in humans. In previous work, we have shown that drugs that have been successfully repositioned have different chemical properties than those that have not. Hence, there is an opportunity to use machine learning to prioritize drug-like molecules as candidates for future repositioning studies. We have developed a feature engineering and machine learning that leverages data from publicly available drug discovery resources: RepurposeDB and DrugBank. ChemVec is the chemoinformatics-based feature engineering strategy designed to compile molecular features representing the chemical space of all drug molecules in the study. ChemVec was trained through a variety of supervised classification algorithms (Naïve Bayes, Random Forest, Support Vector Machines and an ensemble model combining the three algorithms). Models were created using various combinations of datasets as Connectivity Map based model, DrugBank Approved compounds based model, and DrugBank full set of compounds; of which RandomForest trained using Connectivity Map based data performed the best (AUC=0.674). Briefly, our study represents a novel approach to evaluate a small molecule for drug repositioning opportunity and may further improve discovery of pleiotropic drugs, or those to treat multiple indications.


2021 ◽  
Vol 1 ◽  
Author(s):  
Jianhu Zhang ◽  
Xiuli Zhang ◽  
Yuan Sh ◽  
Benliang Liu ◽  
Zhiyuan Hu

Background: Parkinson’s disease (PD), Alzheimer’s disease (AD) are common neurodegenerative disease, while mild cognitive impairment (MCI) may be happened in the early stage of AD or PD. Blood biomarkers are considered to be less invasive, less cost and more convenient, and there is tremendous potential for the diagnosis and prediction of neurodegenerative diseases. As a recently mentioned field, artificial intelligence (AI) is often applied in biology and shows excellent results. In this article, we use AI to model PD, AD, MCI data and analyze the possible connections between them.Method: Human blood protein microarray profiles including 156 CT, 50 MCI, 132 PD, 50 AD samples are collected from Gene Expression Omnibus (GEO). First, we used bioinformatics methods and feature engineering in machine learning to screen important features, constructed artificial neural network (ANN) classifier models based on these features to distinguish samples, and evaluated the model’s performance with classification accuracy and Area Under Curve (AUC). Second, we used Ingenuity Pathway Analysis (IPA) methods to analyse the pathways and functions in early stage and late stage samples of different diseases, and potential targets for drug intervention by predicting upstream regulators.Result: We used different classifier to construct the model and finally found that ANN model would outperform the traditional machine learning model. In summary, three different classifiers were constructed to be used in different application scenarios, First, we incorporated 6 indicators, including EPHA2, MRPL19, SGK2, to build a diagnostic model for AD with a test set accuracy of up to 98.07%. Secondly, incorporated 15 indicators such as ERO1LB, FAM73B, IL1RN to build a diagnostic model for PD, with a test set accuracy of 97.05%. Then, 15 indicators such as XG, FGFR3 and CDC37 were incorporated to establish a four-category diagnostic model for both AD and PD, with a test set accuracy of 98.71%. All classifier models have an auc value greater than 0.95. Then, we verified that the constructed feature engineering filtered out fewer important features but contained more information, which helped to build a better model. In addition, by classifying the disease types more carefully into early and late stages of AD, MCI, and PD, respectively, we found that early PD may occur earlier than early MCI. Finally, there are 24 proteins that are both differentially expressed proteins and upstream regulators in the disease group versus the normal group, and these proteins may serve as potential therapeutic targets and targets for subsequent studies.Conclusion: The feature engineering we build allows better extraction of information while reducing the number of features, which may help in subsequent applications. Building a classifier based on blood protein profiles using deep learning methods can achieve better classification performance, and it can help us to diagnose the disease early. Overall, it is important for us to study neurodegenerative diseases from both diagnostic and interventional aspects.


Sign in / Sign up

Export Citation Format

Share Document